Inventiva (IVA) Other Non Operating Income (2020 - 2022)
Inventiva (IVA) posted quarterly Other Non Operating Income of $109.7 million for Q4 2024, up 26105.49% year-over-year from N/an in Q1 2024, and up 1297.39% quarter-over-quarter from -$9.2 million in Q2 2024.
Analysis
Inventiva (IVA) Other Non Operating Income (2020 - 2022) Analysis & Trends
Inventiva's Other Non Operating Income history runs 4 years deep, the most recent figure standing at $109.7 million for Q4 2024.
- In Q4 2024, Other Non Operating Income rose 26105.49% year-over-year to $109.7 million; the TTM figure through Dec 2024 stood at $109.7 million (up 26105.49% YoY), while the FY2024 annual figure was $109.7 million, up 26105.49% from the prior year.
- Other Non Operating Income for Q4 2024 stood at $109.7 million, up from -$9.2 million in the prior quarter.
- The five-year high for Other Non Operating Income was $109.7 million in Q4 2024, with the low at -$9.2 million in Q2 2024.
- The 4-year median for Other Non Operating Income is $7727.6 (2020), against an average of $14.4 million.
- Peak annual rise in Other Non Operating Income reached 26105.49% in 2024, while the deepest fall reached 418.3% in 2024.
- Inventiva's Other Non Operating Income stood at -$1101.5 in 2020, then surged by 157250.38% to $1.7 million in 2021, then sank by 75.82% to $418540.6 in 2023, then soared by 26105.49% to $109.7 million in 2024.
- Business Quant data shows IVA's Other Non Operating Income at $109.7 million in Q4 2024, -$9.2 million in Q2 2024, and $418540.6 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Inventiva | 893.85 Mn | 893.85 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 4.10 Mn |
| Sep 22, 2022 | 1.91 Mn |
| Dec 31, 2021 | -4.42 Mn |
| Jun 30, 2021 | -9.09 Mn |
| Mar 31, 2021 | 4.44 Mn |
| Dec 31, 2020 | -751,142.61 |
| Mar 31, 2020 | 11,039.39 |